Paper41889736
Fusobacterium nucleatum Lipopolysaccharides Disrupt the Interaction of Siglec‑7 to Sialoglycans Expressed on Mammalian Cells.
Gumah Adam Ali M and 11 others. JACS Au, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Fusobacterium nucleatum Lipopolysaccharides Disrupt the Interaction of Siglec‑7 to Sialoglycans Expressed on Mammalian Cells. Papers, record 41889736. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41889736
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Fusobacterium nucleatum Lipopolysaccharides Disrupt the Interaction of Siglec‑7 to Sialoglycans Expressed on Mammalian Cells.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References57
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 28135570 | The structure of the LPS O-chain of Fusobacterium nucleatum strain 25586 containing two novel monosaccharides, 2-acetamido-2,6-dideoxy-l-altrose and a 5-acetimidoylamino-3,5,9-trideoxy-gluco-non-2-ulosonic acid. | Carbohydr Res | 2017 | https://conductscience.org/library/papers/28135570 | PubMed |
| 2 | 31143186 | Sugar Free: Novel Immunotherapeutic Approaches Targeting Siglecs and Sialic Acids to Enhance Natural Killer Cell Cytotoxicity Against Cancer. | Front Immunol | 2019 | https://conductscience.org/library/papers/31143186 | PubMed |
| 3 | 22467657 | Colonic epithelial cells express specific ligands for mucosal macrophage immunosuppressive receptors siglec-7 and -9. | J Immunol | 2012 | https://conductscience.org/library/papers/22467657 | PubMed |
| 4 | 26258433 | Sialic Acid Glycoengineering Using an Unnatural Sialic Acid for the Detection of Sialoglycan Biosynthesis Defects and On-Cell Synthesis of Siglec Ligands. | ACS Chem Biol | 2015 | https://conductscience.org/library/papers/26258433 | PubMed |
| 5 | 40285643 | Insights into Siglec-7 Binding to Gangliosides: NMR Protein Assignment and the Impact of Ligand Flexibility. | Adv Sci (Weinh) | 2025 | https://conductscience.org/library/papers/40285643 | PubMed |
| 6 | 15292262 | Negative regulation of T cell receptor signaling by Siglec-7 (p70/AIRM) and Siglec-9. | J Biol Chem | 2004 | https://conductscience.org/library/papers/15292262 | PubMed |
| 7 | 38509359 | A distinct Fusobacterium nucleatum clade dominates the colorectal cancer niche. | Nature | 2024 | https://conductscience.org/library/papers/38509359 | PubMed |
| 8 | 34065256 | Siglec Ligands. | Cells | 2021 | https://conductscience.org/library/papers/34065256 | PubMed |
| 9 | 39507251 | Bidirectional signals generated by Siglec-7 and its crucial ligand tri-sialylated T to escape of cancer cells from immune surveillance. | iScience | 2024 | https://conductscience.org/library/papers/39507251 | PubMed |
| 10 | 41311924 | Fusobacterium nucleatum Lipopolysaccharides O‑Antigen Defines a Novel Siglec‑7 Binding Epitope. | JACS Au | 2025 | https://conductscience.org/library/papers/41311924 | PubMed |
| 11 | 31138648 | The ceramide moiety of disialoganglioside (GD3) is essential for GD3 recognition by the sialic acid-binding lectin SIGLEC7 on the cell surface. | J Biol Chem | 2019 | https://conductscience.org/library/papers/31138648 | PubMed |
| 12 | 29491407 | Cell-based glycan arrays for probing glycan-glycan binding protein interactions. | Nat Commun | 2018 | https://conductscience.org/library/papers/29491407 | PubMed |
| 13 | 23029261 | Engagement of Siglec-7 receptor induces a pro-inflammatory response selectively in monocytes. | PLoS One | 2012 | https://conductscience.org/library/papers/23029261 | PubMed |
| 14 | 29753950 | Structure of the LPS O-chain from Fusobacterium nucleatum strain MJR 7757 B. | Carbohydr Res | 2018 | https://conductscience.org/library/papers/29753950 | PubMed |
| 15 | 17082868 | Concise synthesis of the (+/-)-Nb-desmethyl-meso-chimonanthine. | Chem Commun (Camb) | 2006 | https://conductscience.org/library/papers/17082868 | PubMed |
| 16 | 33627655 | Sialic acids in pancreatic cancer cells drive tumour-associated macrophage differentiation via the Siglec receptors Siglec-7 and Siglec-9. | Nat Commun | 2021 | https://conductscience.org/library/papers/33627655 | PubMed |
| 17 | 28199859 | Structure of the LPS O-chain from Fusobacterium nucleatum strain 10953, containing sialic acid. | Carbohydr Res | 2017 | https://conductscience.org/library/papers/28199859 | PubMed |
| 18 | 16790787 | Sialic acid-binding immunoglobulin-like lectin 7 mediates selective recognition of sialylated glycans expressed on Campylobacter jejuni lipooligosaccharides. | Infect Immun | 2006 | https://conductscience.org/library/papers/16790787 | PubMed |
| 19 | 33197108 | Structure of the O-Antigen and the Lipid A from the Lipopolysaccharide of Fusobacterium nucleatum ATCC 51191. | Chembiochem | 2021 | https://conductscience.org/library/papers/33197108 | PubMed |
| 20 | 27085506 | Sialic Acid Mimetics to Target the Sialic Acid-Siglec Axis. | Trends Biochem Sci | 2016 | https://conductscience.org/library/papers/27085506 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41889736
GET https://conductscience.org/api/papers/v1/41889736/references?page=2